BIO-Europe brings together global biopharma innovators to create partnerships that fuel the next generation of therapies.
But every successful collaboration-whether a new target, a licensing deal, or a clinical milestone-depends on one thing: high-quality, standardized biomedical data.

The reality? Omics, clinical, and real-world data are often messy, siloed, and incompatible - making them unusable for AI and advanced analytics. This data fragmentation is one of the biggest barriers to accelerating R&D and making confident investment decisions.

Elucidata solves this challenge with an AI-powered data platform that unifies scattered, heterogeneous biomedical data into a single, actionable foundation. We automate every step of the data lifecycle from ingestion and quality control to deep harmonization, ensuring your data is clean, contextualized, compliant, and AI-Ready at scale.

Leading biopharma organizations use Elucidata to:

• Eliminate data silos across omics, clinical, and RWD sources
• Speed up target identification and biomarker discovery
• De-risk clinical programs through better-quality data
• Build unified data foundations that attract partners and investors

Let’s discuss how AI-Ready data can accelerate your pipeline and strengthen your partnering strategy. Meet our Founder & CEO, Abhishek Jha at BIO-Europe 2025.

‍